Markert, Christoph Dr. med.Universität HeidelbergHeidelberg
Publikationsliste einschränken
Publikationsjahre
Publikationstypen
Sprache
Co-Autoren (Uni Heidelberg)
- Wirsching, Theresia (2)
- Blank, Antje (2)
- Schweizer, Yvonne (2)
- Hafner-Blumenstiel, Verena (2)
- Hohmann, Nicolas (1)
- Fuchs, Ines Verena (1)
- Mathes, Kristin (1)
- Witt, Lukas (1)
- Kastner, Ida Maria (1)
- Carls, Alexandra (1)
- Urban, Stephan (1)
- Grün, Barbara (1)
- Suzuki, Yosuke (1)
- Mier, Walter (1)
- Czock, David (1)
- Eichbaum, Christine (1)
Co-Autoren (extern)
Neueste Publikationen in heiBIB 
(ingesamt sind 12 Publikationen erfasst)
- Suzuki, Yosuke: Ultra-sensitive and selective quantification of endothelin-1 in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry / Yosuke Suzuki, Lukas Witt, Walter Mier, Gerd Mikus, Christoph Markert, Walter E. Haefeli, Jürgen Bur… . - 7 S.
In: Journal of pharmaceutical and biomedical analysis, ISSN 1873-264X. 142(2017), S. 84-90
DOI: 10.1016/j.jpba.2017.04.038
- Blank, Antje: First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B / Antje Blank, Christoph Markert, Nicolas Hohmann, Alexandra Carls, Gerd Mikus, Thorsten Lehr, Alexand… . - 7 S.
In: Journal of hepatology, ISSN 1600-0641. 65(2016), 3, S. 483-489
DOI: 10.1016/j.jhep.2016.04.013
- Markert, Christoph: The effect of induction of CYP3A4 by St John's Wort on ambrisentan plasma pharmacokinetics in volunteers of known CYP2C19 genotype / Christoph Markert, Ida Maria Kastner, Regina Hellwig, Peter Kalafut, Yvonne Schweizer, Michael Marcu… , 2015. - 6 S.
In: Basic & clinical pharmacology & toxicology, ISSN 1742-7843. 116(2015), 5, Seite 423-428
DOI: 10.1111/bcpt.12332
- Markert, Christoph: Influence of St. John’s wort on the steadystate pharmacokinetics and metabolism of bosentan / Christoph Markert, Prisca Ngui, Regina Hellwig, Theresia Wirsching, Ida Maria Kastner, Klaus-Dieter … , 2014. - 9 S.
In: International journal of clinical pharmacology and therapeutics. 52(2014), 04, Seite 328-336
DOI: 10.5414/CP202048
- Markert, Christoph: Lack of a clinically significant interaction of grapefruit juice with ambrisentan and bosentan in healthy adults / Christoph Markert, Theresia Wirsching, Regina Hellwig, Jürgen Burhenne, Johanna Weiss, Klaus-Dieter … , 2014. - 8 S.
In: International journal of clinical pharmacology and therapeutics. 52(2014), 11, Seite 957-964
DOI: 10.5414/CP202164
- Eichbaum, Christine: Pre-systemic elimination of tilidine : localization and consequences for the formation of the active metabolite nortilidine / Christine Eichbaum, Kristin Mathes, Jürgen Burhenne, Christoph Markert, Antje Blank and Gerd Mikus, 2015. - 5 S.
In: Basic & clinical pharmacology & toxicology, ISSN 1742-7843. 116(2015), 2, Seite 129-133
DOI: 10.1111/bcpt.12328
- Markert, Christoph: CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers / C. Markert, J. Burhenne, J. Weiss, G. Mikus and W. E. Haefeli. - 2 S.
In: Clinical pharmacology & therapeutics, ISSN 1532-6535. 95(2014), 3, S. 250-251
DOI: 10.1038/clpt.2013.188
- Markert, Christoph: Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers / Christoph Markert, Yvonne Schweizer, Regina Hellwig, Theresia Wirsching, Klaus-Dieter Riedel, Juerge… , 2014. - 8 S.
In: British journal of clinical pharmacology, ISSN 1365-2125. 77(2014), 1, Seite 141-148
DOI: 10.1111/bcp.12177
- Fuchs, Ines Verena: Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A activity / Ines Fuchs, Verena Hafner-Blumenstiel, Christoph Markert, Jürgen Burhenne, Johanna Weiss, Walter Emi… . - 7 S.
In: European journal of clinical pharmacology, ISSN 1432-1041. 69(2013), 3, S. 507-513
DOI: 10.1007/s00228-012-1388-1
- Katzenmaier, Stephanie Katharina: Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using a limited sampling strategy / S Katzenmaier, C Markert, K-D Riedel, J Burhenne, WE Haefeli and G Mikus, 21 September 2011. - 8 S.
In: Clinical pharmacology & therapeutics, ISSN 1532-6535. 90(2011), 5, Seite 666-673
DOI: 10.1038/clpt.2011.164
IDs
Links
Markert, Christoph in ...
Export Publikationsliste
heiBIB
Bei fehlerhaften oder unvollständigen Angaben wenden Sie sich bitte an biblio@ub.uni-heidelberg.de.
Informationen zu heiBIB (inkl. Einbettung der Publikationslisten in eigene WWW-Seiten).
